History A 50 y/o was referred for evaluation of azotemia. 10 yrs ago, he experienced sudden onset of pain on his right big toe. His serum uric acid was.

Slides:



Advertisements
Similar presentations
1 Oxypurinol for Gout Arthritis Drugs Advisory Committee June 2, 2004 Cardiome Pharma Corp Vancouver, BC Canada.
Advertisements

1. Describe the pathogenesis of hyperuricemia and gout Goup C1 Group C1.
Prepared by D. Chaplin Chronic Renal Failure. Prepared by D. Chaplin Chronic Renal Failure Progressive, irreversible damage to the nephrons and glomeruli.
Heel pain in an adult male Hatem H Eleishi, MD Lecturer of Rheumatology, Cairo University June 2004.
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
1 Alterations of Renal and Urinary Tract Function Chapter 36.
Pathology of the Kidney and Its Collecting System
The Kidneys Major Topics for Discussion Review of anatomy and physiology Congenital anomalies Glomerular diseases Vascular diseases Kidney stones Neoplasia.
Glomerular Diseases Dr. Atapour Differential diagnosis and evaluation of glomerular disease.
{ Gout and Bursitis Asfand Baig.   Inflammatory arthritis associated with hyperuricaemia* and intra-articular sodium urate crystals Gout.
Purine Degradation & Gout (Musculoskeletal Block)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Pathophysiology of Disease: Chapter 16 ( ) RENAL DISEASE: OVERVIEW AND ACUTE RENAL FAILURE Pathophysiology of Disease: Chapter 16 ( ) Jack.
Arthritis New Zealand Gout Georgina Greville RN Arthritis Educator.
Gout.
 Gout is characterized by elevated uric acid concentrations in blood and urine due to variety of metabolic abnormalities that include overproduction.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Uric acid xiaoli.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Uric Acid Metabolism & Gout
Renal Pathology. Introduction: 150gm: each kidney 1700 liters of blood filtered  180 L of G. filtrate  1.5 L of urine / day. Kidney is a retro-peritoneal.
Proteinuria DR Badi AlEnazi Consultant pediatric endocrinology and diabetologest.
Diagnosis of gout.
Kidneys and Urinary Tract
More than 100 different disorders
Definition of Gout Definition of Gout Pathological classification Pathological classification History of Gout History of Gout Gout Aetiology & Pathogenesis.
Ricki Otten MT(ASCP)SC
Primary glomerular diseases Talia Weinstein MD PhD Sourasky Medical Center.
Renal Pathology. Introduction Glomerular diseases Tubular and interstitial diseases Diseases involving blood vessels Cystic diseases Tumors Renal Pathology.
J Winterbottom 2005 Chronic Renal Failure Jean Winterbottom Clinical Educator MRI.
Gout Gouty Arthritis By Mike Parenteau.
Obstructive Uropathy Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
Four Stages of Gout  Asymptomatic hyperuricemia Elevated levels of uric acid in the blood but no other symptoms Does not require treatment  Acute gout/Acute.
Clinical Approach to a Child with Hematuria Careful history, physical examination, urinary dipstick & urinalysis.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
“You’re the doctor” – a urinary system review Prof John Simpson.
GOUT A metabolic disease in which tissue deposition of crystals of monosodium urate occurs from supersaturated extracellular fluids and results in one.
SEVERE DISSEMINATED CUTANEOUS GOUT -CASE REPORT- Irina Tudose1, Olguta Anca Orzan2, Diana Petrache2, Prof. Dr. Calin Giurcaneanu2 1 Pathology Department,
Aims Renal Pathology Readings: Acute renal failure
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Pathology of pyelonephritis, Nephrolithiasis and Cystitis
Lecture – 3 – Major renal syndromes Dr.Hazem.K.Al-Khafaji MBCHB.D.M.FICMS.
Gout Treatment Megan Chan, PGY-2 UHCMC Gout Acute gouty arthritis = monosodium urate crystals in synovial fluid leukocytes – Serum urate ≥ 6.8 =
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
Renal Pathophysiology III : Diseases that affect the kidney and urinary tract Acute and chronic renal failure.
Angelo L Gaffo Kenneth G Saag Core Evidence 2009:4 25–36
Clinical Decision on A Diagnostic Test. Clinical Question In a middle aged man with primary gout and azotemia, can a urine uric acid to creatinine ratio.
PA Days Presentation Brian K. Shrawder, PA-S LHU.
StagesClinical Features (1)Asymptomatic hyperuricemiahigh uric acid level is present but without symptoms (2) Acute Gouty Arthritishigh uric acid level.
Glomerular diseases typical case reports morphology Doc. MUDr. Zdeňka Vernerová, CSc., MUDr. Martin Havrda.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
AOA NEPHROLOGY REVIEW March 18, A 29 year old woman is being evaluated to find the cause of her urine turning a dark brown color after a recent.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
Presentation by JoAnn Czech RN/CDS St. Cloud Hospital.
Uric acid nephropathy 신장내과 R4 최선영. Endogenous production of uric acid Purine catabolism hypoxanthine xanthine Uric acid allantoin XO UO allopurinol -
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
RENAL PATHOLOGY FOR REHABILITATION STUDENTS
CLS 1113 Introduction to Clinical Laboratory Practices
IgA nephropathy 2014년 8월 6일 R1 황규환.
History Salient Features Physical Exam
Pathology for year 2, unit 3
presentation: nephrotic syndrome
Drug Therapy of Gout 1.
Clinical Features. This disorder usually presents either with the
Gout By: Ben Shoaf.
Gouty Nephropathy American Journal of Kidney Diseases
IgA Nephropathy Southwest Nephrology Symposium February 24th 2018.
Presentation transcript:

History A 50 y/o was referred for evaluation of azotemia. 10 yrs ago, he experienced sudden onset of pain on his right big toe. His serum uric acid was elevated. He was diagnosed to have gout and was prescribed medication but he was poorly compliant. The gouty attacks recurred lately hence, he decided to undergo thorough check- up. He denies dysuria, flank pain or hesitancy. He has nocturia. Physical Exam BP is 120/70 Obese numerous tophi in his metacarpo-phalangea l elbow joint no edema Salient Features A 50 y/o obese male diagnosed 10 years ago to have gout with gouty attacks recurring lately and was referred for evaluation of azotemia Patient experiences nocturia but there is no dysuria, flank pain or hesitancy, and edema BP is 120/70 Numerous tophi in his metacarpo-phalangeal elbow joint

Clinical Impression Gouty nephropathy – Patients with prolonged forms of hyperuricemia are predisposed to a more chronic tubulointerstitial disorder, often referred to as gouty nephropathy – Distinctive feature: presence of crystalline deposits of uric acid and monosodium urate salts in kidney parenchyma – Clinically, gouty nephropathy is an insidious cause of renal insufficiency. – Early in its course GFR may be near normal despite focal morphologic changes in medullary and cortical interstitium, proteinuria and diminished urinary concentrating ability

Algorithm/Sequence of Events Renal Deposition of Urates Pelvic Calculi Parenchymal Urate (microtophi) Tubular Uric Acid (obstruction) Gout Renal Insufficiency

Differential Diagnosis Diabetic Nephropathy – Kimmelstiel-Wilson syndrome – a progressive kidney disease caused by angiopathy of capillaries in the kidney glomeruli – characterized by nephrotic syndrome and diffuse glomerulosclerosis.

Spectrum of Disease Diagram Lower testing threshold Upper testing threshold Pretest probability Do nothing. Rule out the disease Treat the patient without waiting for more information Do additional diagnostic exams to confirm diagnosis (testing zone) 20 % 70% % 60%